eurekalert.org
Possible biomarker identified for Crohn’s disease with arthritis type
This study points to a possible microbiome biomarker (M. gnavus) tied to joint inflammation in people with Crohn’s disease, which could help explain why some patients develop arthritis and might eventually inform diagnostics or treatments.
Adults with Crohn’s disease (especially those with joint pain), gastroenterologists and rheumatologists, microbiome researchers, and clinicians studying extraintestinal manifestations of IBD.
What To Know
Researchers at Weill Cornell analyzed stool and blood (serum) from people with Crohn’s disease with and without spondyloarthritis to look for bacteria targeted by circulating IgG antibodies.
They found that the gut bacterium Mediterraneibacter gnavus was more commonly IgG-coated in people with Crohn’s plus spondyloarthritis than in those without joint inflammation or healthy controls, and IgG levels correlated with joint disease activity scores.
The team also reported distinct gut microbiota profiles when comparing Crohn’s patients with axial (spine/lower back) versus peripheral (limb) spondyloarthritis, suggesting different bacterial associations with different arthritis types. The study suggests M.
gnavus might serve as a biomarker linked to joint inflammation in some people with Crohn’s disease and raises the possibility of immune responses to specific gut bacteria contributing to extraintestinal symptoms.
Next steps and limits: This is early-stage research reporting associations; the authors note further work is needed to identify specific bacterial epitopes, test causality, and determine whether targeting these bacteria could become a therapy.
Findings come from a single cohort analyzed for IgG-coated bacteria and report associations rather than proof of cause. The authors and journal data suggest further research is needed before clinical changes are warranted.
